Doenças Infecciosas

URI Permanente desta comunidade

http://repositorio.ufes.br/handle/10/17577
Programa de Pós-Graduação em Doenças Infecciosas

Centro: CCS
Telefone: (27) 3335 7504
URL do programa: http://doencasinfecciosas.ufes.br/pos-graduacao/PPGDI

Navegar

Navegando Doenças Infecciosas por Assunto "Adesão ao medicamento"

Agora exibindo 1 - 1 de 1
  • Nenhuma Miniatura disponível
    Item
    Estudo longitudinal de adesão de pacientes iniciantes em terapia antirretroviral: estratégias farmacêuticas entre pessoas vivendo com HIV/AIDS
    (Universidade Federal do Espírito Santo, 2022-03-29) França, Patrícia de Oliveira; Cerutti Junior, Crispim; https://orcid.org/0000000294854191; http://lattes.cnpq.br/4257067087979999; https://orcid.org/0000-0002-9671-2306; http://lattes.cnpq.br/7577648597815230; Teixeira, Carlos Graeff; https://orcid.org/0000000327250061; http://lattes.cnpq.br/0464152494769261; Pinto Neto, Lauro Ferreira da Silva; http://lattes.cnpq.br/1528710938091794; Palaci, Moises; https://orcid.org/0000000320136071; http://lattes.cnpq.br/2602694352713051
    To achieve the benefits of antiretroviral therapy (ART) and ensure infection control, it is of utmost importance that patients maintain a degree of adherence to therapy higher than 90%. Thus, the aim of this study was to carry out an epidemiological investigation of the adherence process of HIV/AIDS patients starting ART in 2017. We conducted a longitudinal prospective, quasiexperimental study to evaluate the rate of adherence to ART during a pharmaceutical intervention in the Medication Dispensing Unit of a University Hospital in Vitória, Espírito Santo. The sample consisted of 109 patients who met the predetermined inclusion criteria. It was found that 76.1% of the population was male, 46.8% were brown, 80.7% were single, 33.9% had 12 or more years of schooling, 42.2% were heterosexual, 61.5% used alcohol, 21.1% used drugs and 39.4% were smokers. The average age of patients was 34.7 years (SD = 12.4). Among them, 81.7% started treatment with more than 1000 viral copies/ml and 68.8% with TCD4+ lymphocyte count greater than 350 cells/mm3 . The adherence profile of patients in this study was calculated through medication dispensing profile in the pharmacy and by self-report. It was observed that the mean adherence rate was 93.25% and 93.31% at 12 and 24 months of follow-up. There were 992 sessions of pharmaceutical interventions, of which 43.6% were associated with patient education, 19.7% were related to drug interactions, and 14.4% corresponded to monitoring the patient's clinical evolution. Of all participants, after 24 months of follow-up, 80.8% of them were adherent. We found an association between sociodemographic, behavioural, social and clinical variables and adherence, and identified as the main factors that contributed to non-adherence the illicit drug use [adjusted odds ratio (ajOR=3.9), 95% confidence interval (95% CI= 1.09-13.98) (p= 0.037)], and the difficulty to access to the medicines [ajOR=3.7, 95% CI= 1.15- 11.64 (p= 0.028)]. Pharmaceutical counselling played an important role in all interventions, increasing medication adherence.